Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma

Guo Gord Zhu,Daniel Ramirez,Wen Chen,Chao Lu,Lu Wang,Denise Frosina,Achim Jungbluth,Peter Ntiamoah,Khedoudja Nafa,Patrick J Boland,Meera R Hameed,Patrick J. Boland,Meera R. Hameed

DOI: https://doi.org/10.1016/j.humpath.2020.07.002

IF: 3.526

2020-10-01

Human Pathology

Abstract:<p>Conventional chordoma is a rare slow-growing malignant tumor of notochordal origin primarily arising at base of skull and sacrococcygeal bones. Chordoma may arise from its benign counterpart, benign notochordal cell tumors, and can also undergo dedifferentiation progressing into dedifferentiated chordoma. No study has directly compared the genomic alterations among these tumors comprising a morphologic continuum. Our prior study identified frequent chromosome 3p loss of heterozygosity and minimum deleted regions on chromosome 3 encompassing <em>SETD2</em>, encoding a histone methyltransferase involved in the trimethylation of lysine-36 of histone H3 (H3K36me3). In the current study we expanded our study to include 65 sacral conventional chordoma cases, 3 benign notochordal cell tumors and 2 dedifferentiated chordomas using SNP array, targeted Next-Generation Sequencing analysis and immunohistochemistry. We performed immunohistochemical analysis of histone, H3K36me3 and investigated whether there is any association between the clinical behavior and recurrent chromosome or aneuploidy, or H3K36me3 protein expression. We found that there is increased genomic instability from benign notochordal cell tumor to conventional chordoma, to dedifferentiated chordoma. The highly recurrent genomic aberration, chromosome 3p loss of heterozygosity (occurred in 70% of conventional chordomas), is correlated with longer relapse free survival, but not with overall survival or metastasis free survival in sacral chordoma. Chordomas demonstrate variable patterns and levels of H3K36me3 expression and reduced expression of H3K36me3 showed marginally significant correlation with longer relapse free survival. Copy number alterations in the genes encoding H3K36me3 methylation transferase complex and demethylase may account for the altered H3K36me3 expression levels.</p>

pathology